Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The Patient: 32-year-old, 16 weeks pregnant, with pre-existing Type 2 diabetes managed on insulin
By using GLP-1 agonists, such as semaglutide, this treatment can help you lose weight by suppressing your appetite, reducing food cravings, and increasing satiety.
Maximum Weight Loss (Novo Nordisk Ecosystem) CagriSema REDEFINE 1 demonstrated 20.4% weight loss with 60% of patients achieving 20%+ reduction, substantially exceeding semaglutide alone
Lifestyle changes Tirzepatide, under the brand names Mounjaro and Zepbound, is intended to be used with diet changes and regular exercise
The Canadian healthcare systems approach to obesity and prediabetes continues evolving
Stop waiting for your body to catch up
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
